Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 260 | 970 | 1,270 | 1,290 | 1,920 |
| Marketable Securities | 0 | 0 | 0 | 0 | 700 |
| Receivables | 2 | 2 | 2 | 2 | 30 |
| Other current assets | 2,178 | 2,008 | 2,308 | 2,368 | 1,860 |
| TOTAL | $2,440 | $2,980 | $3,580 | $3,660 | $4,510 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1,380 |
| Other Non-Current Assets | 215 | 225 | 235 | 245 | 255 |
| TOTAL | $215 | $225 | $235 | $245 | $1,635 |
| Total Assets | $3,410 | $3,990 | $4,640 | $4,760 | $5,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 0 | 1,680 |
| Accounts payable and accrued liabilities | 510 | 480 | 450 | 460 | 440 |
| Other current liabilities | 1,610 | 1,610 | 1,480 | 1,090 | 0 |
| TOTAL | $2,130 | $2,100 | $1,930 | $1,560 | $2,120 |
| Non-Current Liabilities | |||||
| Long Term Debt | 360 | 360 | 360 | 360 | 350 |
| Other Non-Current Liabilities | 5,600 | 5,590 | 5,580 | 5,570 | 5,560 |
| TOTAL | $5,960 | $5,950 | $5,940 | $5,930 | $5,910 |
| Total Liabilities | $8,090 | $8,060 | $7,890 | $7,500 | $8,040 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,565,404 | N/A | N/A | N/A | N/A |
| Common Shares | 15,650 | 15,650 | 15,650 | 15,600 | 15,600 |
| Retained earnings | -54,850 | -54,230 | -53,420 | -52,870 | -52,480 |
| Other shareholders' equity | 60 | 60 | 70 | 70 | 50 |
| TOTAL | $-4,680 | $-4,060 | $-3,240 | $-2,740 | $-2,370 |
| Total Liabilities And Equity | $3,410 | $4,000 | $4,650 | $4,760 | $5,670 |